KRISTIN O'BANION: Open Payments
NPI 1689397366 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,370 in 62 payments from 14 companies in 2025. Trend: 2023 $576 · 2024 $751 · 2025 $1,370
Food & beverage: $1,271Education: $99
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $329 |
| ABBVIE INC. | 13 | $296 |
| GENZYME CORPORATION | 5 | $179 |
| UCB, Inc. | 10 | $168 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $126 |
| Janssen Biotech, Inc. | 4 | $69 |
| Amgen Inc. | 2 | $50 |
| Organon LLC | 3 | $37 |
| Incyte Corporation | 1 | $24 |
| Krystal Biotech Inc | 1 | $23 |
Products named: DUPIXENT, Bimzelx, RINVOQ, ILUMYA, BOTOX, TREMFYA, SKYRIZI, OTEZLA.
Industry payments across TX — which companies pay providers there.
